PHILIP D. MURPHY GOVERNOR Dear Friends, STATE OF NEW JERSEY OFFICE OF THE GOVERNOR P.O. BOX 001 TRENTON 08025 (009) 292-0000 February 8, 2024 On behalf of the State of New Jersey, I am pleased to congratulate BioNJ on its 31 51 Annual Dinner Meeting and Innovation Celebration. Since its inception, BioNJ has brought together industry leaders from across the life sciences ecosystem and promoted policies that facilitate important progress. BioNJ has made significant contributions to a critical part of our New Jersey economy by driving medical i1movation. Our administration plans to do all we can to build on these effo1is, and we hope that you will join us. Special recognition is in order for tonight's distinguished honorees: William H. Lewis for the Dr. Sol J. Barer Award, and Lisa Salberg, Amadou Diarra, and Mark Peters for the Heart of BioNJ Awards. I would also like to congratulate the numerous Innovator Award Honorees who received FDA approval in 2023. Their dedication to Biomedical advancement is admirable, and I join with all those in attendance in applauding their service. Best wishes for a successful and memorable event. My very best, fft.M1ef Governor
Welcome to BioNJ’s 31st Annual Dinner Meeting and Innovation Celebration honoring the exceptional medical innovation coming from our great State of New Jersey. Because Patients Can’t Wait®, tonight’s program is dedicated to the Patients, caregivers, innovators, advocates, policymakers and service providers who are working together to bring new therapies and cures to those in need around the world. The Garden State remains a leading innovation powerhouse — with over 50% of all new FDA approvals in 2023 coming from companies with a footprint in New Jersey. This evening, we are proud to present those New Jersey companies with a BioNJ Innovator Award. It is these innovative medicines and therapies that help Patients live better, more productive and longer lives — benefiting the entire healthcare system, the economy and society as a whole. Similarly, we are pleased to present the Heart of BioNJ Award to three extraordinary Patient advocates: Lisa Salberg, Founder and CEO, Hypertrophic Cardiomyopathy Association; Amadou Diarra, Ph.D., Senior Vice President, Global Policy, Advocacy & Government Affairs, Bristol Myers Squibb and Chair, BioNJ; and Mark Peters, PharmD, Senior Director, Patient Advocacy, Genmab. In honor of the Patients who embolden us every day, we are humbled to feature Lupus Warrior Shanelle Gabriel as she shares her personal journey with Lupus through an inspirational Spoken Word. To complement Shanelle’s special presentation, our Keynote, award-winning photographer Rick Guidotti, will pay tribute to Patients around the world. We are thrilled to present a poem written by Shanelle in honor of our industry as well as an iconic photo of students at the Siloe School for the Blind in South Africa captured by Rick as a special keepsake for everyone who helped us celebrate this evening. Please enjoy this special memento found on each table. Once again, we are delighted to have Dr. Sol J. Barer with us to present the 16th Annual Dr. Sol J. Barer Award for Vision, Innovation and Leadership to respected industry leader and mentor William H. Lewis, JD, MBA, Chair and CEO of Insmed. Widely regarded for his passion for Patients, Mr. Lewis’ visionary thinking and transformative leadership have helped to redefine the biopharma landscape while revolutionizing Patient care – often pioneering the way for others to follow. And the impact he had on BioNJ as our 2022-23 Chair is indelibly etched in our hearts and minds and the annals of BioNJ. As ever, we have so many people to thank for their generosity, dedication and contributions to making this meeting possible. We are indebted to our Board of Trustees, our Annual Dinner Meeting and Innovation Celebration Planning Committee led by Dr. Andrew Latham of Merck & Co. and Marisol Mendez Peron of Genmab, our most generous Sponsors, New Jersey’s vibrant life sciences ecosystem and our ubertalented BioNJ Team. Thank you all for being here and for all you do throughout the year. Because Patients Can’t Wait®, Amadou Diarra, Ph.D. Debbie Hart Board Chair President & CEO BioNJ BioNJ Senior Vice President, Global Policy, Advocacy & Government Affairs Bristol Myers Squibb Because Patients Can’t Wait® Because Patients Can’t Wait ® 1
CHAIR Amadou Diarra, Ph.D. Senior Vice President, Global Policy, Advocacy & Government Affairs Bristol Myers Squibb VICE CHAIR Emer Leahy, Ph.D., MBA President & CEO PsychoGenics PRESIDENT & CEO Debbie Hart, MS, APR BioNJ IMMEDIATE PAST CHAIR Will H. Lewis, JD, MBA Chair & CEO Insmed TREASURER Jayne C. Gershkowitz Chief Patient Advocate Amicus Therapeutics SECRETARY Christopher Mortko, Ph.D., MBA Vice President & Head HQ Search & Evaluation Business Development & Licensing Merck Corporate Licensing BOARD MEMBERS Sol J. Barer, Ph.D. Former Chair & CEO Celgene Corporation & Chair of the Board Teva Pharmaceutical Industries Maya Bermingham, JD Senior Vice President Public Policy & Government Affairs Regeneron Pharmaceuticals Carrie Brown Head, U.S. Communications Sanofi Samuele Butera, MPP President, Pulmonary Hypertension and Retina Janssen Pharmaceuticals Christopher Cozic Executive Vice President & Chief People Officer Genmab Tina Deignan, Ph.D. Senior Vice President, US Therapeutic Area Head, Oncology Novartis Pharmaceuticals Matthew B. Klein, M.D., M.S., FACS CEO PTC Therapeutics Michele Korfin, R.Ph., MBA Chief Operating Officer & Chief Commercial Officer Gamida Cell Susan L. Levinson, Ph.D. CEO BioAegis Therapeutics John Maki CEO Bayesian Biotech Anthony S. Marucci, MBA Founder, President, CEO & Director Celldex Therapeutics Scott Megaffin President & CEO Adiso Therapeutics Christine Ann Miller, MBA President & CEO Melinta Therapeutics Jeffrey A. Nau, Ph.D., MMS CEO Nau Consulting Gregory Oakes, MBA President & CEO Landos Biopharma Andrew L. Pecora, M.D., FACP, CPE Chair & CEO Outcomes Matter Innovations Spiro Rombotis, MPH, MBA President & CEO Cyclacel Pharmaceuticals Christopher J. Schaber, Ph.D. Chair, President & CEO Soligenix Michael Schoen Chief of Staff & Special Advisor to the CEO BeiGene Robert (Bob) Smith Former Senior Vice President Global Gene Therapy Business Pfizer BOARD ADVISORS ACADEMIC ADVISOR Reynold A. Panettieri, Jr., M.D. Professor of Medicine, Robert Wood Johnson Medical School; Vice Chancellor, Translational Medicine & Science; Director, Rutgers Institute for Translational Medicine & Science Rutgers Biomedical and Health Sciences, Emeritus Professor, University of Pennsylvania ACCOUNTING ADVISOR Brian Wilcomes, CPA Principal Strategy & Analytics Deloitte & Touche INVESTOR ADVISOR George Heinrich, M.D. Vice Chair & CEO New Jersey Health Foundation & Foundation Venture Capital Group LEGAL ADVISOR Emilio Ragosa Managing Partner DLA Piper STATE GOVERNMENT OFFICIAL ADVISOR Kathleen Coviello Chief Economic Transformation Officer New Jersey Economic Development Authority (NJEDA) TECHNOLOGY ADVISOR Kelly Watson Vice President & Senior Partner IBM Consulting ADDITIONAL ADVISORS Teresa Leste Principal, Life Sciences Strategy & Analytics Deloitte James Sapirstein, R.Ph., MBA President, Chair & CEO First Wave BioPharma 2 2023 BioNJ Board of Trustees
Andrew H. Latham, Ph.D. – Co-Chair Merck & Co. Marisol Mendez Peron – Co-Chair Genmab James Bruno, MBA Chemical & Pharmaceutical Solutions John Cahill Jones Lang LaSalle Marshall Calman, MBA, PCC LeaderStrong Richard Clements WhizAI Bill DeStefano Marsh Nikki Frazier Centri Business Consulting Jayne Gershkowitz Amicus Therapeutics Ethan Hasbrouck Bristol Myers Squibb Tracy Henrikson, MBA Eli Lilly & Company Paul Howard, P.h.D Amicus Therapeutics Jack Levitt, MBA, EMTM LeaderStrong Tricia Roman 325 Christopher J. Schaber, Ph.D. Soligenix Judith Sheft, MBA, MSc New Jersey Commission on Science, Innovation & Technology Alain Van Loo Assetive Joel Wagner, CPA EY Jordan Warshafsky, MBA Ashton Tweed Brian Wilcomes, CPA Deloitte & Touche Debbie Hart President & CEO [email protected] Randi Bromberg Sr. Vice President Communications & Marketing [email protected] Maria Carapucci Meeting Coordinator [email protected] Donna Gibbons Sr. Vice President, Operations [email protected] Cheri Hennessy Vice President, Member Engagement & Strategic Partnerships [email protected] Pavita Howe, MBA Vice President, Innovation & Entrepreneurship [email protected] Ian McLaughlin, Ph.D. Vice President, Government Affairs [email protected] Denise Machado Executive Director, Member Operations [email protected] Debbie Mennito Executive Director, Programs & People Services [email protected] Dawn Piccioni Director, Marketing & Design [email protected] Cheri Potts Office Manager [email protected] Dana Sacco Sr. Executive Assistant to the CEO [email protected] Danielle Slaboda Member Services Manager [email protected] Peggy Schell Talent Services & Public Policy Assistant [email protected] Ann Wieczkowski Executive Director, Accounting Operations [email protected] BioNJ TEAM 2024 Annual Dinner Meeting Committee Members 3
INNOVATION SPONSOR Insmed HEART OF BioNJ SPONSORS Acadia Pharmaceuticals ♦ Ferring Pharmaceuticals CENTERPIECE SPONSORS Genmab ♦ PHC Corporation of North America PARTING GIFT SPONSORS Bristol Myers Squibb ♦ Hackensack Meridian Health NJ Health Foundation ♦ Pfizer ♦ Thermo Fisher Scientific TABLE SPONSORS Acrotech BioPharma Inc. ♦ Amicus Therapeutics Boehringer Ingelheim Animal Health ♦ Conner Strong & Buckelew ♦ Daiichi Sankyo Deloitte ♦ Eli Lilly ♦ EY ♦ Faegre Drinker ♦ Gilead ♦ Johnson & Johnson J.P. Morgan ♦ McKinsey & Company ♦ Melinta Therapeutics ♦ Mercer & Marsh Morgan Stanley ♦ NewAmsterdam Pharma ♦ Novartis ♦ Princeton University PTC Therapeutics ♦ RSM USA ♦ Rutgers Office for Research ♦ Teva Pharmaceutical 2024 ANNUAL DINNER MEETING & INNOVATION CELEBRATION Thank You to Our Sponsors 4
COCKTAIL SPONSORS BeiGene ♦ Centri Consulting ♦ DLA Piper ♦ Eisai ♦ Insights Driven Research Kyowa Kirin ♦ Novo Nordisk ♦ Sanofi DESSERT SPONSORS Barnes & Thornburg ♦ Johnson & Johnson ♦ Lexicon Pharmaceuticals Merck & Co. ♦ NJMEP ♦ Permevo ♦ Phathom Pharmaceuticals ♦ PsychoGenics STUDENT SPONSORS NJ Health Foundation ♦ Sanofi MEDIA SPONSORS NJBIZ ♦ New Jersey Business Magazine VIDEO SPONSOR Pulse Productions Tweet about BioNJ’s Annual Dinner Meeting and Innovation Celebration! #PatientsCantWait #BioNJAnnualDinnerMeeting 5
THE BOARD OF TRUSTEES OF BioNJ WELCOMES YOU TO THE 2024 ANNUAL DINNER MEETING, NETWORKING EVENT AND INNOVATION CELEBRATION February 8, 2023 Hilton East Brunswick 4:45 p.m. – 5:45 p.m. Networking Reception 6:00 p.m. – 8:30 p.m. Dinner Program, Networking and Innovator Awards 8:30 p.m. – 9:30 p.m. Dessert and Networking Reception OPENING CEREMONIES WELCOME Debbie Hart President & CEO, BioNJ OPENING ADDRESS Governor Phil Murphy LEADERSHIP TRANSITION Amadou Diarra, Ph.D. Senior Vice President, Global Policy, Advocacy & Government Affairs Bristol Myers Squibb Emer Leahy, Ph.D., MBA President & CEO, PsychoGenics 2024 ANNUAL DINNER MEETING & INNOVATION CELEBRATION 6
SPOKEN WORD Lupus Warrior Shanelle Gabriel HEART OF BioNJ AWARDS Presented to Amadou Diarra, Ph.D. Senior Vice President, Global Policy, Advocacy & Government Affairs Bristol Myers Squibb Mark Peters, PharmD Senior Director, Patient Advocacy, Genmab Lisa Salberg Founder & CEO, Hypertrophic Cardiomyopathy Association INNOVATOR AWARDS DINNER AND NETWORKING THE DR. SOL J. BARER AWARD FOR VISION, INNOVATION AND LEADERSHIP Presented by Sol J. Barer, Ph.D. Former Chair & CEO, Celgene Corporation and Chair of the Board, Teva Pharmaceutical Industries to William H. Lewis, J.D., MBA Chair & CEO, Insmed HONORING PATIENTS AROUND THE WORLD Rick Guidotti Founder, Positive Exposure DESSERT AND NETWORKING RECEPTION 7 Saluting Innovators and the Patients Who Inspire Them
• AbbVie for Epkinly™ • Acadia Pharmaceuticals for Daybue™ • Acrotech Biopharma Inc. for Ryzneuta® • Amicus Therapeutics for Pombiliti™ + Opfolda™ • Bausch + Lomb for Miebo™ • Bristol Myers Squibb for Augtyro™ • CorMedix for DefenCath™ • Daiichi Sankyo for Vanflyta® • Eisai for Leqembi® • Eli Lilly for Jaypirca® and Omvoh™ • Evive Biotech for Ryzneuta® • Gamida Cell for Omisirge™ • GC Biopharma USA for Alyglo™ • Genmab for Epkinly™ • GSK for Arexvy, Jesduvroq and Ojjaara • Ipsen for Sohonos™ • Iveric BIO: An Astellas Company for Izervay™ • Johnson & Johnson for Talvey™ • Lexicon Pharmaceuticals for Inpefa® • Melinta Therapeutics for Rezzayo™ • Nestlé Health Science for Vowst™ • Novartis for Fabhalta® • Novo Nordisk for Rivfloza™ • Octapharma for Balfaxar® • Pfizer for Abrysvo™, Elrexfio™, Litfulo™, Ngenla™, Paxlovid™, Penbraya™, Velsipity™ and Zavzpret™ • Protalix Biotherapeutics for Elfabrio® • Pharming for Joenja® • Regeneron Pharmaceuticals for Veopoz™ • Sanofi for Altuviiio® and Beyfortus™ Plus, FDA Animal Drug Approvals: • Boehringer Ingelheim Animal Health USA for NexGard Combo®, NexGard Plus® and Senvelgo® • Zoetis Animal Health for Librela™ Innovaor Awards Honoring 2023 FDA Approvals 8
The 2024 Heart of BioNJ Award Honorees Presented to Extraordinary Patient Advocates 9 Amadou Diarra, Ph.D. Senior Vice President Global Policy, Advocacy & Government Affairs Bristol Myers Squibb & Board Chair, BioNJ Dr. Diarra has devoted his 32-year career at Bristol Myers Squibb to ensuring that no Patient is left behind. He leads an integrated organization focused on global external environment dynamics, working with key stakeholders, including Patient support organizations, healthcare professionals, policymakers and industry associations to improve Patient access and health outcomes. Dr. Diarra led the BioNJ Health Equity in Clinical Trials initiative featuring three groundbreaking strategies: the assessment of New Jersey’s leadership in bringing diverse Patients into trials, creating a portal where organizations can share their health equity strategies and a MBA Business Plan Competition wherein eight diverse teams from MBA business schools competed for the best business plan to increase diversity in trials. This meaningful work is ongoing, and its impact will continue for years to come. Mark Peters, PharmD Senior Director, Patient Advocacy, Genmab Dr. Peters has devoted his career to serving Patients, families and care partners living through a diagnosis of cancer through his work at Bristol Myers Squibb, CancerCare and now at Genmab. In addition, he is inspiring and training the next generation of Patient advocacy professionals as a professor at the Ernest Mario School of Pharmacy at Rutgers. Still, some of Dr. Peters most significant work includes co-founding a non-profit organization that has helped thousands of underserved Hunterdon County patients receive over $25 million dollars of free prescription medicine and important health counseling over the last 20 years. Lisa Salberg Founder & CEO, Hypertrophic Cardiomyopathy Association (HCMA) Just 1 in 250 to 500 people – including Ms. Salberg’s daughter, niece and nephew – is affected by Hypertrophic Cardiomyopathy (HCM). Ms. Salberg herself was diagnosed at the age of 12 when she was told by her doctor that “she could die at any moment and that CPR was not likely to save her life”. Meanwhile years later in the wake of the tragic loss of her sister, due to medical errors and mismanagement related to HCM, our honoree created a website offering crucial information and support to fellow families and Patients grappling with HCM, with the hope of preventing others from enduring similar heartache. Now, 28 years later, the Hypertrophic Cardiomyopathy Association is an international organization serving more than 20,000 Patients and their families. Its work has led to groundbreaking research and the development of cutting-edge treatment options.
Sol J. Barer, Ph.D. Former Chair & CEO Celgene Corporation Chair of the Board Teva Pharmaceutical Industries Dr. Barer spent most of his professional career with the Celgene Corporation. He was Chair from January 2011 until June 2011, Executive Chair from June 2010 until January 2011 and Chair and Chief Executive Officer from May 2006 until June 2010. Previously he was appointed President in 1993 and Chief Operating Officer in 1994 before assuming the CEO position. He also served as Senior Vice President, Science and Technology, and Vice President/General Manager, Chiral Products, from October 1990 to October 1993, and Vice President, Technology, from September 1987 to October 1990. Dr. Barer was the founder of the biotechnology group at the Celanese Research Company which was subsequently spun out to form Celgene. Dr. Barer currently serves as Chair of the Board of the public companies Teva Pharmaceutical Industries and Neximmune and the private company Centrexion and is a Director of 3D Biotherapeutics and Zephyr.ai. He is the Founding Chair of the HMH Center for Discovery and Innovation. He is a Founder of MIG, an organization dedicated to helping Israeli biotech entrepreneurs and is a Venture Advisor to the Israel Biotechnology Fund as well as an advisor to biopharma companies. In 2011, Dr. Barer was Chair of the University of Medicine and Dentistry of New Jersey Governor’s Advisory Committee which resulted in sweeping changes in the structure of New Jersey’s medical schools and public research universities. He previously served as a Commissioner of the NJ Commission on Science and Technology. He was a member of the Board of Trustees of Rutgers University (until 2013). He also served two terms as Chair of the Board of Trustees of BioNJ. Dr. Barer was named to the “Worldview 100” (Scientific American’s 100 most influential figures in today’s world of biotechnology) in 2015, named one of “25 Leadership Legends of NJ” (NJBIZ) in 2012, “The 50 Most Powerful People in N.J. Health Care,” in 2012, inducted into the NJBIZ Hall of Fame in 2011 and was named as one of NJ’s top 10 scientists by New Jersey Business in 2008. Dr. Barer has received numerous professional awards. The Dr. Sol J. Barer Award for Vision, Innovation and Leadership 10 10
William H. Lewis, J.D., M.B.A. Chair & CEO, Insmed Mr. Lewis joined Insmed in 2012 as President and Chief Executive Officer and as a member of the board of directors. He became Chair of the Board of Directors in November 2018. Mr. Lewis is the former Co-Founder, President and Chief Financial Officer of Aegerion Pharmaceuticals, Inc., and previously spent more than 10 years working in investment banking in the U.S. and Europe. He also previously worked for the U.S. government. Mr. Lewis holds a Bachelor of Arts degree cum laude from Oberlin College as well as a Master of Business Administration and a Juris Doctor with Honors from Case Western Reserve University. Mr. Lewis is a member of the Board of Trustees of Case Western Reserve University and a member of the Board of Trustees of BioNJ. He is also Chair of the Board of Directors of NewAmsterdam Pharma. The 2024 Dr. Sol J. Barer Award for Vision, Innovation and Leadership Recipient 11
12 Philip D. Murphy took the oath of office for a second term as New Jersey’s 56th governor on January 18, 2022. He is the first Democratic governor to serve a second term in 44 years. Governor Murphy currently serves as Chair of the Democratic Governors Association. The Governor also completed his year-long Chairmanship of the National Governors Association in July of 2023. He is the first governor to have led both organizations simultaneously. Since taking office in 2018, Governor Murphy has focused on building a stronger, fairer, and more affordable New Jersey. Under his leadership, New Jersey has made strides in growing the State’s economy and creating new economic opportunity while shrinking longstanding inequities, restoring fiscal responsibility to state government while expanding critical investments, and delivering real tax fairness and relief, including 14 tax cuts for New Jersey’s middle class and seniors. Governor Murphy guided New Jersey from being the epicenter of the COVID-19 pandemic to a model state for following the highest level of public health standards and data-driven response, implementing among the nation’s most robust vaccination efforts and fostering a strong economic recovery. Over the course of two years, the Murphy Administration has provided billions of dollars in state and federal relief to small businesses, schools, homeowners, tenants, and landlords, and middle-class families. Governor Murphy has put a special emphasis on making New Jersey more welcoming to both established high-tech enterprises and start-up companies in the innovation economy. In January 2021, he enacted a new set of state economic incentives, focused on promoting the growth of new small businesses and innovative startups, enacting the State’s first tax credits for historic preservation, and expanding credits for brownfields reclamation and redevelopment, among other initiatives. Under the Governor’s leadership, New Jersey has emerged as a leader in the deployment of clean energy technologies, including one of the nation’s most-aggressive proposals for the development of offshore wind. He helped break ground at both the Paulsboro Marine Terminal and the South Jersey Wind Port in Salem County, where more than 1,500 new jobs will help secure New Jersey’s place as a global leader in offshore wind component manufacturing and logistics. The Governor has also focused on making New Jersey a leading location for film, television, and digital production, enacting a new incentive program that drew more than half-a-billion dollars in investment to New Jersey in 2021. Under Governor Murphy’s leadership, New Jersey had already emerged as a national leader on a number of nationally significant issues prior to the pandemic. He secured the dignity of working families by moving to a $15-per-hour minimum wage, guaranteeing earned sick days, and expanding paid family leave. The Governor has enacted initiatives to provide a tuition-free public college education for qualified students. He has embraced policies that have driven down the cost of healthcare. He has expanded protections for the State’s immigrant and LGBTQIA+ communities. And he has enacted and proposed gun safety laws to combat gun violence and promote responsible gun ownership. Governor Murphy has also made New Jersey a model state for social justice through fostering the State’s nascent adult-use cannabis industry, enacting among the country’s strongest automatic voter registration measures, restoring voting rights to individuals on parole or probation, expunging the records of numerous non-violent offenders, and creating the nation’s strongest provisions for environmental justice, alongside numerous other new laws. He has also put a focus on eliminating stigma and promoting a compassionate approach to tackling opioid misuse. Opening Address By Governor Phil Murphy 12
Ms. Gabriel is a poet, singer, lupus warrior and educator who has toured the globe. Diagnosed in 2004, Ms. Gabriel is also a lupus advocate who has spoken alongside the President of the National Institute of Health, graced the cover page of USA Today, featured in Women’s Health magazine, and featured on the Lifetime Network about her continued battle with lupus. She currently is on the Patient Advisory Board for CISCRP (Center for Information and Study on Clinical Research Participation) and speaks on the Patient experience in various arenas. When Ms. Garbriel is not on a stage, she’s speaking with and advocating for young people. With over 15 years of work as an educator, school administrator and non-profit specialist, Ms. Gabriel facilitates workshops on anti-racist, culturally responsive and healing arts practices, utilizing poetry and hip-hop as mediums for these conversations. Shanelle Gabriel Mr. Guidotti, an award-winning photographer, has worked in NYC, Milan, Paris and London for a variety of high-profile clients, including Yves St Laurent, Revlon and L’Oreal. He founded POSITIVE EXPOSURE after a chance encounter in 1997 with a young lady living with albinism at a bus stop in New York City. As an artist, he was taken by her extraordinary beauty. In a quest for a better understanding of albinism, Mr. Guidotti sought out medical textbooks, where he was affronted by the dehumanizing images depicting disease, lacking all humanity. It was this experience which forced him to turn his lens from the more traditional ideas of beauty to the beauty and richness of human diversity — challenging societal attitudes and reshaping bias against and perceptions of individuals living with genetic, physical and behavioral differences. Rick Guidotti 13 Honoring Patients Around the World
Thank You to Our Upper Tier Members MARKET MAKER PREFERRED EXECUTIVE 14
Innovation Associate 325 4M Therapeutics, Inc. 6S Pharma, Inc. A.J. O’Connor Associates AbbVie, Inc. Acadia Pharmaceuticals Adiso Therapeutics, Inc. ADMA Biologics, Inc. Advant-EDGE Solutions of Middle Atlantic, Inc. Ahersla Health Alliant Insurance Services Amicus Therapeutics, Inc. ApiJect Systems, Corp Archer Insights Ascendia Pharmaceuticals, LLC Ash Ingredients, Inc. Ashton Tweed, LTD Aspirant Assetive August eTech BalinBac Therapeutics, Inc. Barer & Son Capital, LLC Barnes & Thornburg Bayesian Biotech BDO USA, LLP BeiGene USA, Inc. Bench International Bezwada Biomedical, LLC Biggins Lacy Shapiro & Company, LLC Bio Calibration Company, Inc. BioAdvance BioAegis Therapeutics Inc. BioBridges BioCentriq BioEnsemble, LLC Biogen Bioloupe Inc. BioMarin Pharmaceutical, Inc. Boehringer Ingelheim Animal Health USA, Inc. BOME Pharma, LLC Boyden Summit, LLC Bristol Myers Squibb Buchanan Ingersoll & Rooney PC CAI - Commissioning Agents, Inc. CBIZ Insurance Services, Inc. CBRE Cellares Corporation Celldex Therapeutics, Inc. Celularity Inc. Centri Business Consulting CFGI CGI CHA Chartwell Partners Chemical and Pharmaceutical Solutions Chromocell Corporation Chugai Pharma USA, Inc. Clinical Services International CMIC CMO USA CohnReznick, LLP CompassMSP Conner Strong & Buckelew ConSynance Therapeutics Control Associates, Inc. Controlled Contamination Services Cornerstone Pharmaceuticals, Inc. Cornerstone Search Group, LLC Couragene, Inc. CP Biotools, LLC Cresa Global Inc. Crowley Law, LLC Crystal Pharmatech, Inc. CSS Building Services, Inc. Cushman & Wakefield of NJ, LLC Cyclacel Pharmaceuticals, Inc. Deloitte Delphine Diagnostics, Inc. Delta Dental of New Jersey DLA Piper, LLP eClinical Solutions EisnerAmper Element Six Creative Group Eli Lilly and Company EmphyCorp, Inc. Enalare Therapeutics, Inc. Endomedix, Inc. Enzene, Inc. EpiBone, Inc. Evotec, Inc. Evrys Bio, LLC EY US, LLP Faegre Drinker Biddle & Reath Fedsprout Ferring Pharmaceuticals, Inc. First Wave BioPharma, Inc. Fisher Scientific Company, LLC FloatR, Inc. Gamida Cell Genentech Genetika Plus USA GENEWIZ from Azenta Life Sciences Genmab Gennao Bio GenVault Biorepository GeoSera Gilead Sciences, Inc. Global Strategic Advisory Government Systems Technologies, Inc. (GSTi) GSG Scientific, LLC GSK Hart & Chin Associates, LLC Helsinn Therapeutics, Inc. Hepion Pharmaceuticals, Inc. Herspiegel Hetero USA HLW Architecture, LLC Hongyi Therapeutics HopeAI HotSpot Therapeutics IBM IDR (Insights Driven Research) Iktos, Inc. IMA Clinical Research Impact Business Information Solutions, Inc. Insmed Incorporated Integrated Project Management Company, Inc. Intercept Pharmaceuticals, Inc. Interius BioTherapeutics, Inc. IvericBio, An Astellas Company Jackson Lewis P.C. Jazz Pharmaceuticals Jesra Advisors, LLC Johnson & Johnson Janssen Jones Lang LaSalle JPMorgan Chase Bank NA J-STAR Research, Inc. BioNJ Members as of 2/5/2024 15
Jubilant Therapeutics, Inc. Kanvas Biosciences, Inc. KatalX Kathera Bioscience Katten Muchin Rosenman, LLP Kenox Pharmaceuticals, Inc. Kognitic, Inc. Korn Ferry (US) Kyowa Kirin, Inc. Lachman Consultant Services, Inc. Lactiga, Inc. Landos Biopharma LeaderStrong Legend Biotech USA, Inc. Lexicon Pharmaceuticals LifeSci Partners Lisata Therapeutics, Inc. Lisure Technology Co. Lumanity Lura Health Magic Hat Consulting Mancino Burfield Edgerton Marcum, LLP Marsh, Inc. MassMutual NJ-NYC Matchbook, Inc. Matinas BioPharma Holdings, Inc. McCarter & English, LLP McKinsey & Company Med-Con Technologies Medifvu, LLC Medix Melinta Therapeutics Mercadien Mercer Health & Benefits, LLC Merck & Co., Inc. MetasTx, LLC Mintz, Levin, Cohn, Ferris, Glovsky & Popeo, PC MiraKare Mitsubishi Tanabe Pharma America, Inc. MMR Consulting USA Inc. Mnemo Therapeutics, Inc. Modal Technology Corporation Modern Meadow, Inc. Morgan Lewis Morgan Stanley NAKI Therapeutics NanoPharmaceuticals, LLC NDA Group NemaGen Discoveries, Inc. Neoventech, LLC Neumentum, Inc. NeuroPair, Inc. NeuroTechR3, Inc. NewAmsterdam Pharma NJ Bio, Inc. NJ Health Foundation NLB Services, Inc. NovaRock Biotherapeutics, Ltd. Novartis Pharmaceuticals Corporation Novo Nordisk OLI Technologies, Inc. Optinose Organon OsseoPrint 3D Otsuka America Pharmaceutical, Inc. Ott Management Solutions, LLC Outcomes Matter Innovations, LLC Outlook Therapeutics, Inc. P360 Palatin Technologies, Inc. Panavance Therapeutics Inc. Passage Bio PendoTECH Permevo Peroff Saunders P.C. Pfizer Inc. PhageNova Bio, Inc. Pharmatech Solutions, LLC Phathom Pharmaceuticals PHC Corporation of North America PHP Environmental Consulting, Inc. PMV Pharmaceuticals, Inc. PNC Bank PR Newswire PricewaterhouseCoopers, LLP Princeton Creative Princeton Property Partners, LLC Prosper Digital Therapeutics, Inc. PsychoGenics, Inc. PTC Therapeutics, Inc. Pulse Health Radford/Aon Rarity Health Regeneron Pharmaceuticals, Inc. RegenLabUSA RegenSkin LLC Reset Pharma reVision Therapeutics, Inc. RLDatix Life Sciences RSM US, LLP S1 BioPharma, Inc. Sampled Sanguine Biosciences Sannova Analytical Sanofi Sauvie Inc. Science Branding Communications SciMar ONE, Inc. SciSafe, Inc. Sentrimed SHINKEI Therapeutics Signum Biosciences, Inc. Silence Therapeutics Simphotek Inc. Six Therapeutics, Inc. Soligenix, Inc. Somnia Therapeutics, LLC Sonder Research X Sonnet BioTherapeutics, Inc. Starton Therapeutics Stateam, LLC Stone Creek Construction Group, LLC Strategies for Success Int’l Surplus Solutions, LLC Syridex Bio Syzent Partners, LLC Tactical Therapeutics, Inc. Taiho Oncology, Inc. TAXIS Pharmaceuticals, Inc. TCG GreenChem, Inc. Tech Council Ventures Teclison USA Limited tenXclinical TEVA Pharmaceuticals Tevogen Bio, Inc. Tharimmune, Inc. The Swan Group Thrive Buildings BioNJ Members as of 2/5/2024 16
Thunderbolt Health Tonix Pharmaceuticals, Inc. TriRadial Solutions, LLC Ubuntu Research Inc. Vaneltix Pharma, Inc. Vertex Pharmaceuticals Verve Group Consulting Viatris Visual Intelligence, LLC Vital Start Health Vitalief, Inc. Vitruviae Vyome Therapeutics, Inc. WhizAI WithumSmith+Brown, PC Worldwide IP Solutions LLC WuXi Biologics Y-mAbs Therapeutics, Inc. Zambon USA Ltd. Institution Choose New Jersey Consulate General of Denmark Coriell Institute for Medical Research ExportJERSEY Hackensack University Medical Center Institute for Life Science Entrepreneurship Kean University Mid-Atlantic - Eurasia Business Council New Jersey Business & Industry Association New Jersey Economic Development Authority (NJEDA) New Jersey Institute of Technology (NJIT) New Jersey Manufacturing Extension Program (NJMEP) New Jersey State Chamber of Commerce Office of Business Engagement, Middlesex County PA Biotechnology Center PHL Life Sciences Princeton Innovation Center BioLabs Princeton Mercer Regional Chamber Princeton University Rowan University Rutgers, The State University of New Jersey Somerset County Business Partnership Somerset County Office of Planning, Policy and Economic Development Students 2 Science, Inc. TechUnited:NJ The College of New Jersey TCNJ Patient Advocacy Adult Polyglucosan Body Disease Research Foundation AliveAndKickn American Behcet’s Disease Association American Cancer Society American Diabetes Association Armor Up for Life Brooke Healey Foundation CancerCare CheckRare Childhood Arthritis and Rheumatology Research Alliance CARRA Children’s Cardiomyopathy Foundation CJD Foundation Community Liver Alliance Congenital Hyperinsulinism International Crohn’s & Colitis Foundation, NJ Chapter Crossroads4Hope Curemonos Danon Disease Foundation, Inc. EveryLife Foundation for Rare Diseases EverythingALS Familial Dysautonomia Foundation Global Genes Global Lyme Alliance HEADstrong Foundation Hepatitis B Foundation Hope Loves Company Hypertrophic Cardiomyopathy Association IGA Nephropathy Foundation of America Immune Deficiency Foundation International Cancer Advocacy Network (ICAN) Kaleidoscope of Hope Ovarian Cancer Foundation Lung Cancer Circle of Hope Lupus and Allied Diseases Association MSA NJ Multiple Sclerosis Association of America My Life Is Worth It NAMI New Jersey National Infusion Center Association National Kidney Foundation National Multiple Sclerosis Society, NJ Metro Chapter National Organization for Rare Disorders (NORD) Neurofibromatosis, Inc. Northeast New Jersey Association of Mental Health and Addiction Agencies, Inc. (NJAMHAA) NJ Center for Tourette Syndrome and Associated Disorders Inc. Patient Access Network (PAN) Foundation Professional Patient Advocates in Life Sciences Project 8p Sepsis Alliance Susan G. Komen North Jersey The Family Resource Network The Leukemia & Lymphoma Society Thea’s Star of Hope U.S. Pain Foundation Advisory Biotechnology Innovation Organization International BC Trade and Investment Flanders Investment & Trade BioNJ Members as of 2/5/2024 17
BioNJ Salutes Our Sponsors 18
19 2024 BioNJ Board of Trustees CHAIR Emer Leahy, Ph.D., MBA President & CEO PsychoGenics VICE CHAIR Samuele Butera, MPP President, Pulmonary Hypertension and Retina Janssen Pharmaceuticals PRESIDENT & CEO Debbie Hart, MS, APR BioNJ IMMEDIATE PAST CHAIR Amadou Diarra, Ph.D. Senior Vice President, Global Policy, Advocacy & Government Affairs Bristol Myers Squibb TREASURER Jayne C. Gershkowitz Chief Patient Advocate Amicus Therapeutics SECRETARY Christopher Mortko, Ph.D., MBA Vice President & Head HQ Search & Evaluation Business Development & Licensing Merck Corporate Licensing BOARD MEMBERS Sol J. Barer, Ph.D. Former Chair & CEO Celgene Corporation & Chair of the Board Teva Pharmaceutical Industries Maya Bermingham, JD Senior Vice President Public Policy & Government Affairs Regeneron Pharmaceuticals Carrie Brown Head, U.S. Communications Sanofi Christopher Cozic Executive Vice President & Chief People Officer Genmab Tina Deignan, Ph.D. Senior Vice President, US Therapeutic Area Head, Oncology Novartis Pharmaceuticals Matthew B. Klein, M.D., M.S., FACS CEO PTC Therapeutics Michele Korfin, R.Ph., MBA Chief Operating Officer & Chief Commercial Officer Gamida Cell Susan L. Levinson, Ph.D. CEO BioAegis Therapeutics Will Lewis, JD, MBA Chair & CEO, Insmed John Maki CEO Bayesian Biotech Anthony S. Marucci, MBA Founder, President, CEO & Director Celldex Therapeutics Scott Megaffin President & CEO Adiso Therapeutics Christine Ann Miller, MBA President & CEO Melinta Therapeutics Gregory Oakes, MBA President & CEO Landos Biopharma Andrew L. Pecora, M.D., FACP, CPE Chair & CEO Outcomes Matter Innovations Spiro Rombotis, MPH, MBA President & CEO Cyclacel Pharmaceuticals Christopher J. Schaber, Ph.D. Chair, President & CEO Soligenix Michael Schoen Chief of Staff & Special Advisor to the CEO BeiGene Keely Beck Zipp Vice President, Commercial Strategy and Innovation, Internal Medicine Pfizer BOARD ADVISORS ACADEMIC ADVISOR Reynold A. Panettieri, Jr., M.D. Professor of Medicine, Robert Wood Johnson Medical School; Vice Chancellor, Translational Medicine & Science; Director, Rutgers Institute for Translational Medicine & Science Rutgers Biomedical and Health Sciences, Emeritus Professor, University of Pennsylvania ACCOUNTING ADVISOR Brian Wilcomes, CPA Principal Strategy & Analytics Deloitte & Touche INVESTOR ADVISOR George Heinrich, M.D. Vice Chair & CEO New Jersey Health Foundation & Foundation Venture Capital Group LEGAL ADVISOR Emilio Ragosa Managing Partner DLA Piper STATE GOVERNMENT OFFICIAL ADVISOR Kathleen Coviello Chief Economic Transformation Officer New Jersey Economic Development Authority (NJEDA) TECHNOLOGY ADVISOR Kelly Watson Vice President & Senior Partner IBM Consulting ADDITIONAL ADVISORS Teresa Leste Principal, Life Sciences Strategy & Analytics Deloitte
Amicus is committed to improving the lives of patients and families affected by rare and orphan diseases. An Extraordinary Story in Rare Disease NP-NN-ALL-00050124 www.BTLaw.com
CONGRATULATIONS TO THE 2024 AWARD RECIPIENTS START NOW Bringing 50 Years of excellence in global executive search. Elevate Your Leadership Team to New Heights with Bench International Website: BeiGene.com Twitter: @BeiGeneGlobal LinkedIn: linkedin.com/company/beigene
bms.com © 2024 Bristol-Myers Squibb Company. All rights reserved. We are in the business of breakthroughs—our diverse, promising pipeline is focused on innovative medicines that transform patients’ lives. Our scientists are addressing some of the most challenging diseases of our time. We will never give up our search for more hope, for more patients, around the world. Bristol Myers Squibb is proud to support BioNJ and extends congratulations to Amadou Diarra for being honored with the Heart of BioNJ Award.
The Courage of Patients Inspires Our Work © 2024 Daiichi Sankyo, Inc. TEM-US-NP-0027 1/24 The heroic people who face cancer are why we push to develop and advance new treatments to change the standard of care. We are honored to celebrate with BioNJ the people who are moving science forward. See more of the story. Conner Strong & Buckelew is proud to support BioNJ’s mission to advance the life sciences industry, foster medical innovation and ensure health equity and healthcare affordability. LOOKING FORWARD. GIVING BACK. INSURANCE RISK MANAGEMENT EMPLOYEE BENEFITS CONNERSTRONG.COM George E. Norcross III, Executive Chairman Joseph Buckelew, Chairman Michael Tiagwad, President and Chief Executive Officer Daniel S. Brettler, Senior Partner, National Life Science & Technology Practice Leader
Partners in innovation. Our pursuit of innovation continues to transform the delivery of legal services. Today, and every day, we’re proud to help trailblazing organizations succeed. DLA Piper is proud to support BioNJ. dlapiper.com Emilio Ragosa | ATTORNEY ADVERTISING | MRKT0009233 In the future, health care as we know it will no longer exist. The industry will be defined by radically interoperable data, open yet secure platforms, and consumer-driven care. What role will you play? Now is the time to engineer your advantage. www.deloitte.com/future Realizing the Future of Health™
CORP-US2790 ©2024 Eisai Inc. All rights reserved. January 2024 A t E i s a i , eve r y t h i n g w e d o i s g u i d e d by a s i m p l e p r i n c i p l e : p a t i e n t s a n d t h e i r f a m i l i e s c o m e f i r s t . We s p e n d t i m e w i t h t h e m . We l i s t e n a n d w e l e a r n a b o u t t h e i r l i ve s , t h e i r d e s i r e s a n d t h e i r g r e a t e s t needs. We call this human health care or hhc, g i v i n g f i r s t t h o u g h t s t o p a t i e n t s a n d t h e i r f a m i l i e s a n d h e l p i n g i n c r e a s e t h e b e n e f i t s health care provides. Our hhc mission i s w h a t d r i ve s u s t o d i s c ove r i n n ov a t i ve s o l u t i o n s a n d t h e ra p i e s t h a t h e l p a d d r e s s u n m e t n e e d s w i t h i n t h e communities that we seek to serve. E i s a i i s h o n o r e d t o r e c e i ve t h e Innovator Award from BioNJ. C R E AT I N G HOPE T H R O U G H INNOVATION T O L E A R N M O R E , P L E A S E V I S I T US.EISAI.COM www.Lilly.com
© 2024 Faegre Drinker Biddle & Reath LLP. All Rights Reserved. 553086 faegredrinker.com Collaborators Who Care Whether you’re overcoming regulatory and compliance hurdles, pursuing strategic transactions, advancing public policy initiatives or navigating complex litigation and enforcement matters, our multidisciplinary health and life sciences team is dedicated to your success. Learn more Life sciences deals are back – making the right deals in a time of change 2024 EY M&A Firepower report
We are an international biotech company committed to improving the lives of people with our differentiated antibody medicines. genmab.com Working to transform the future of cancer treatment
Hackensack Meridian Health is proud to support BioNJ on the occasion of its 2024 Dinner Meeting & Innovation Celebration. ■ ■ ■ Best wishes for a successful event! HackensackMeridianHealth.org
We Applaud You Congratulations Will Lewis on being chosen as this year's winner of the Dr. Sol J. Barer Award for Vision, Innovation and Leadership, an honor well deserved. With much admiration, your J.P. Morgan team © 2024 Chase, J.P. Morgan, JPMorgan Chase, and Story by J.P.Morgan are marketing names for certain businesses of JPMorgan Chase & Co. and its affiliates and subsidiaries worldwide (collectively, “JPMC”, “We”, “Our” or “Us”, as the context may require). www.InsightsDrivenResearch.com
A history of breakthrough and transformative collaborations. A culture of teamwork. All aimed at making a profound impact on patients, their families, and our communities. kkna.kyowakirin.com 37706 24 KKNA BioNJ Annual Dinner Meeting Sponsorship Halfpage Ad 02jc.indd 1 1/26/24 2:37 PM At Johnson & Johnson, we believe health is everything. Our strength in healthcare innovation empowers us to build a world where complex diseases are prevented, treated, and cured, where treatments are smarter and less invasive, and solutions are personal. That’s why we’re proud to support BioNJ’s 31st Annual Dinner Meeting and Innovation Celebration, an event that recognizes the achievements of New Jersey’s life science sector and pays tribute to advancements in medical innovation. ©JJSI2024 Solving the toughest health challenges can help communities thrive 1976308_M01R_JAN_Ad_BioNJ.indd 1 1/29/24 3:59 PM
www.LexPharma.com McKinsey & Company is proud to support BioNJ’s 2024 Annual Dinner Meeting & Innovation Celebration. We warmly congratulate tonight’s honorees!
Our companies lead in risk, strategy and people, helping clients navigate a dynamic environment. www.marshmclennan.com
www.Merck.com
Would like to CONGRATULATE WILLIAM H. LEWIS, J.D., MBA on being awarded the Dr. Sol J. Barer Award, as well as the winners of The Innovator Awards and Heart of BioNJ Awards. JUNE 2024: 33RD ANNUAL INNOVATIVE STATE EDITION READ THE DIGITAL ISSUE NOW NJBMAGAZINE.COM PROUD MEDIA SPONSOR: BIONJ 2024 ANNUAL DINNER MEETING
www.NJMEP.org
Congratulations to our Board Chairman, Will Lewis, on your recognition for your extensive contributions to the life sciences industry in New Jersey and beyond.
FIND THE MISSING PIECES WHEN YOU SUBSCRIBE Get all the pieces when you subscribe! http://bit.ly/getnjbiz You deserve the full story - in the easy to read digital or print editions - plus all the perks of being a subscriber VOLUME 37 NUMBER 3 NJBIZ.COM JANUARY 22, 2024 $2.00 Part of the network Ahead Looking The outlook for 2024 from the New Jersey Economic Development Authority, small and medium-sized companies and a newly rebranded 100-year-old business stalwart. Coverage begins on page 2 Also inside Why businesses should build barriers to protect against international cyber threats. Page 13 Spotlight: AI in Business How one New Jersey company is building on its partnership with an English soccer club to broaden its offerings in 2024; and what emerging technology can do for law firm efficiency and productivity. Section begins on page 8
Novo Nordisk Driving Change in Obesity. www.Permevo.com
www.PhathomPharma.com Are you looking for groundbreaking research collaborations that transcend boundaries? Dive into Research with Princeton, your gateway to innovation! • Delve into profiles and research domains of Princeton faculty • Discover the unparalleled expertise of Princeton's departments, institutes, and centers • Learn about our world class scientific facilities that drive discoveries • Get a glimpse of the expansive global network of Princeton researchers Princeton University is a proud partner with Discover your next collaboration!
A Member of PHC Group Performance • Sustainability • Innovation Reduce Uncertainty We Protect Science™ From preservation to incubation, discover how PHCbi brand products lead the industry in reliability. Proudly Celebrating BioNJ and its 2024 Honorees PHC Corporation of North America
www.PsychoGenics.com For PTC Therapeutics, our 25-year history has been filled with bold transformative science delivering on our commitment to bringing more moments to patients and their families living with rare diseases. See how we are pushing the boundaries of innovation at www.ptcbio.com. For PTC Therapeutic 25- with bold trans deli to bringing mo patients and their with ra See h of inn TRANSLATING SCIENCE Transforming Lives Extending life’s moments for people living with rare diseases
Visit rsmus.com/aboutus for more information regarding RSM US LLP and RSM International. Thinking about your business is a big part of ours. PUT OUR LIFE SCIENCES INSIGHTS TO WORK FOR YOU. To make confident decisions about the future, middle market leaders need a different kind of advisor. One who starts by understanding where you want to go and then brings the ideas and insights of an experienced global team to help get you there. Experience the power of being understood. Experience RSM. rsmus.com/lifesciences Research.Rutgers.edu